Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

SELL
$1.97 - $3.69 $492 - $922
-250 Reduced 11.11%
2,000 $6,000
Q1 2023

May 11, 2023

BUY
$2.14 - $3.4 $535 - $850
250 Added 12.5%
2,250 $5,000
Q1 2022

May 11, 2022

BUY
$0.99 - $1.6 $1,980 - $3,200
2,000 New
2,000 $3,000
Q4 2021

Feb 14, 2022

SELL
$1.22 - $1.72 $2,440 - $3,440
-2,000 Closed
0 $0
Q2 2021

Aug 09, 2021

BUY
$1.25 - $1.83 $2,500 - $3,660
2,000 New
2,000 $3,000
Q1 2021

May 14, 2021

SELL
$1.52 - $2.1 $3,040 - $4,200
-2,000 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$1.55 - $2.05 $3,100 - $4,100
2,000 New
2,000 $3,000

Others Institutions Holding GERN

About GERON CORP


  • Ticker GERN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 377,819,008
  • Market Cap $688M
  • Description
  • Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...
More about GERN
Track This Portfolio

Track Tradition Wealth Management, LLC Portfolio

Follow Tradition Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tradition Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tradition Wealth Management, LLC with notifications on news.